Recruiting NA INTERVENTIONAL 2-arm
NCT07187063
Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer
Sponsor: Lahey Clinic
Conditions
Non-muscle Invasive Bladder Cancer (NMIBC)
Interventions
UroAmp Test (Convergent Genomics, Inc.)
Updated 1 time since 2025 Last updated: Sep 18, 2025 Started: Jan 1, 2025 Primary completion: Jan 1, 2029 Completion: Jan 1, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07187063, this NA trial focuses on Non-muscle Invasive Bladder Cancer (NMIBC) and remains actively recruiting participants. Sponsored by Lahey Clinic, it has been updated 1 time since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Lahey Clinic
Data source: Lahey Clinic
For direct contact, visit the study record on ClinicalTrials.gov .